| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |